Jupiter Neurosciences Inc (NASDAQ:JUNS) shares, rose in value, with the stock price up by 14.14% to the previous day’s close as strong demand from buyers drove the stock to $2.18.
Actively observing the price movement in the recent trading, the stock is buoying the session at $1.91, falling within a range of $1.77 and $2.3. Referring to stock’s 52-week performance, its high was $19.51, and the low was $0.51. On the whole, JUNS has fluctuated by 125.44% over the past month.
With the market capitalization of Jupiter Neurosciences Inc currently standing at about $72.17 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-May-15.
The stock’s technical analysis shows that the price of JUNS currently trading nearly 70.54% and 129.40% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 73.06, while the 7-day volatility ratio is showing 25.09% which for the 30-day chart, stands at 25.35%.
A comparison of Jupiter Neurosciences Inc (JUNS) with its peers suggests the former has fared considerably weaker in the market. JUNS showed an intraday change of 14.14% in today’s session so far, and over the past year, it shrunk by -79.63%%.
Data on historical trading for Jupiter Neurosciences Inc (NASDAQ:JUNS) indicates that the trading volumes over the past 10 days have averaged 0.85 and over the past 3 months, they’ve averaged 436.32K. According to company’s latest data on outstanding shares, there are 33.10 million shares outstanding.
Nearly 58.06% of Jupiter Neurosciences Inc’s shares belong to company insiders and institutional investors own 1.14% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 0.28 million shares as on 2025-06-13, resulting in a short ratio of 0.47. According to the data, the short interest in Jupiter Neurosciences Inc (JUNS) stood at 169.00 of shares outstanding as of 2025-06-13; the number of short shares registered in 2025-05-15 reached 0.11 million. This could raise investors’ confidence to be optimistic about the JUNS stock heading into the next quarter.
